Home / Inspections / 822698

FDA Inspection 822698 — Biogen, Inc.

Biogen, Inc. — FEI 1220951

The FDA completed an inspection of Biogen, Inc. on March 15, 2013 in Cambridge, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 15, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cambridge, MA (United States)

Facility

Other inspections at this facility

  • 1190494 (NAI Fri Nov 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1180550 (NAI Fri Sep 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1133055 (VAI Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1130379 (NAI Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1046583 (NAI Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources